Company / Capital Expenditures
biote Corp. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.0M
FY2025
5-year range
$333.0K / $6.4M
FY2022-FY2025
Trend
-22.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $359,000 to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +146.9%.
Improved from $359,000 to $5M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +146.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +146.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 22.0% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0M | -22.0% |
| FY2024 | $6.4M | +1691.1% |
| FY2023 | $359.0K | +7.8% |
| FY2022 | $333.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 22, 2026